DSpace Repositorium (Manakin basiert)

Management of Advanced Therapies in Parkinson’s Disease Patients in Times of Humanitarian Crisis: The COVID-19 Experience

Zur Kurzanzeige

dc.contributor.author Fasano, Alfonso
dc.contributor.author Antonini, Angelo
dc.contributor.author Katzenschlager, Regina
dc.contributor.author Krack, Paul
dc.contributor.author Odin, Per
dc.contributor.author Evans, Andrew H.
dc.contributor.author Foltynie, Thomas
dc.contributor.author Volkmann, Jens
dc.contributor.author Merello, Marcelo
dc.date.accessioned 2020-12-03T14:45:32Z
dc.date.available 2020-12-03T14:45:32Z
dc.date.issued 2020-05-04
dc.identifier.citation Fasano, A., Antonini, A., Katzenschlager, R., Krack, P., Odin, P., Evans, A.H., Foltynie, T., Volkmann, J., Merello, M., 2020. Management of Advanced Therapies in Parkinson’s Disease Patients in Times of Humanitarian Crisis: The COVID-19 Experience. Mov Disord Clin Pract 7, 361–372. https://doi.org/10.1002/mdc3.12965. en_US
dc.identifier.uri https://repositorio.fleni.org.ar/handle/123456789/252
dc.identifier.uri https://doi.org/10.1002/mdc3.12965
dc.description.abstract Background: Although the COVID-19 pandemic is affecting a relatively small proportion of the global population, its effects have already reached everyone. The pandemic has the potential to differentially disadvantage chronically ill patients, including those with Parkinson's disease (PD). The first health care reaction has been to limit access to clinics and neurology wards to preserve fragile patients with PD from being infected. In some regions, the shortage of medical staff has also forced movement disorders neurologists to provide care for patients with COVID-19. Objective: To share the experience of various movement disorder neurologists operating in different world regions and provide a common approach to patients with PD, with a focus on those already on advanced therapies, which may serve as guidance in the current pandemic and for emergency situations that we may face in the future. Conclusion: Most of us were unprepared to deal with this condition given that in many health care systems, telemedicine has been only marginally available or only limited to email or telephone contacts. In addition, to ensure sufficient access to intensive care unit beds, most elective procedures (including deep brain stimulation or the initiation of infusion therapies) have been postponed. We all hope there will soon be a time when we will return to more regular hospital schedules. However, we should consider this crisis as an opportunity to change our approach and encourage our hospitals and health care systems to facilitate the remote management of chronic neurological patients, including those with advanced PD. en_US
dc.language.iso eng en_US
dc.publisher Wiley en_US
dc.rights info:eu-repo/semantics/openAccess
dc.rights.uri https://creativecommons.org/licenses/by/2.5/ar/
dc.subject Parkinson Disease en_US
dc.subject Enfermedad de Parkinson en_US
dc.subject Coronavirus Infections en_US
dc.subject Infecciones por Coronavirus en_US
dc.title Management of Advanced Therapies in Parkinson’s Disease Patients in Times of Humanitarian Crisis: The COVID-19 Experience en_US
dc.type info:eu-repo/semantics/publishedVersion
dc.type info:eu-repo/semantics/article en_US
dc.description.fil Fil: Merello, Marcelo. Fleni. Departamento de Neurología. Servicio de Movimientos Anormales; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina.
dc.description.fil Fil: Fasano, Alfonso. Toronto Western Hospital. Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Centre; Canadá. University of Toronto Toronto. Division of Neurology. University Health Network; Canadá. Krembil Brain Institute; Canadá. The Center for Advancing Neurotechnological Innovation to Application; Canadá.
dc.description.fil Fil: Antonini, Angelo. University of Padua. Department of Neuroscience; Italia.lia.
dc.description.fil Fil: Katzenschlager, Regina. Institute for Neuroimmunological and Neurodegenerative. Department of Neurology and Karl Landsteiner; Austria.
dc.description.fil Fil: Krack, Paul. University of Bern. Bern University Hospital. Center for Parkinson's Disease and Movement Disorders Inselspital. Department of Neurology; Suiza.
dc.description.fil Fil: Odin, Per. Lund University. Department of Clinical Sciences Lund. Division of Neurology; Suecia.
dc.description.fil Fil: Evans, Andrew H. The Royal Melbourne Hospital Victoria. Department of Neurology; Australia.
dc.description.fil Fil: Foltynie, Thomas. University College London. Institute of Neurology. Department of Clinical & Movement Neurosciences; Reino Unido.
dc.description.fil Fil: Volkmann, Jens. Universitätsklinikum Würzburg. Neurologischen Klinik; Alemania.
dc.relation.ispartofVOLUME 7
dc.relation.ispartofPAGINATION 361-372.
dc.relation.ispartofCOUNTRY Estados Unidos
dc.relation.ispartofCITY Nueva York
dc.relation.ispartofTITLE Movement disorders clinical practice
dc.relation.ispartofISSN 2330-1619
dc.relation.ispartofISSN 4
dc.type.snrd info:ar-repo/semantics/artículo es_ES


Dateien zu dieser Ressource

Das Dokument erscheint in:

Zur Kurzanzeige

info:eu-repo/semantics/openAccess Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: info:eu-repo/semantics/openAccess

DSpace Suche


Stöbern

Mein Benutzerkonto

Statistik